Trademark: 79075468
Status Date
Tuesday, September 17, 2019
Registration Number
4069082
Registration Date
Tuesday, December 13, 2011
Filing Date
Thursday, September 17, 2009
Published for Opposition
Tuesday, September 27, 2011
Cancellation Date
Tuesday, September 17, 2019
5 Pharmaceutical preparations and substances for the treatment of bleeding and for tissue sealing; pharmaceutical preparations and substances for use as tissue sealants; haemostatic pharmaceutical compositions; pharmaceutical powder compositions for use as tissue sealants and/or as haemostatic compositions; pharmaceutical compositions for topical application to wounds; pharmaceutical compositions for topical application during surgical procedures for the treatment of bleeding and for tissue sealing; wound dressings; surgical dressings; bandages for dressing wounds; medicated wound dressings impregnated with tissue sealants and/or haemostatic compositions; medicated bandages impregnated with tissue sealants and/or haemostatic compositions; wound dressings, surgical dressings and bandages for dressing wounds, all incorporating tissue sealants and/or haemostatic compositions; pharmaceutical preparations and substances for use in delivery of drugs, genes, other therapeutic products or diagnostic agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of internal bleeding; blood platelet substitutes; pharmaceutical compositions for coating blood vessels for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical compositions for intravascular administration for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical dry powder compositions comprising fibrin polymer for coating the internal surface of blood vessels for the prevention and treatment of cardiovascular diseases and disorders
10 Surgical, medical, dental and veterinary apparatus and instruments for administration of pharmaceutical compositions, namely, drug delivery systems; drug delivery systems, sold empty, for the delivery of pharmaceutical compositions for the treatment of bleeding and/or tissue sealing; drug delivery systems, sold empty, for the topical delivery of powdered pharmaceutical tissue sealants and/or haemostatic compositions; drug delivery systems, sold empty, for the delivery of tissue sealants to an internal or external surface of a patient; drug delivery systems, sold empty, for the delivery of haemostatic compositions by spraying; drug delivery systems, sold empty, for the delivery of pharmaceutical tissue sealants and/or haemostatic compositions during surgical procedures; surgical, medical, dental and veterinary apparatus and instruments for the prevention and treatment of cardiovascular diseases and disorders; drug delivery systems, sold empty, for intravascular delivery of pharmaceutical compositions for the prevention and/or treatment of cardiovascular diseases and disorders
42 Pharmaceutical drug development services; design services of new drug delivery systems; development of pharmaceutical formulations; scientific research and industrial research services in the field of pharmaceuticals and drug delivery systems
The wording "PROFIBRIX" has no meaning in a foreign language.
Apr 17, 2020
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Apr 17, 2020
Death Of International Registration
May 17, 2019
Total Invalidation Processed By The Ib
Mar 28, 2019
Total Invalidation Of Reg Ext Protection Sent To Ib
Mar 28, 2019
Invalidation Processed
Mar 20, 2019
Total Invalidation Of Reg Ext Protection Created
Jul 20, 2018
Cancelled Section 71
Aug 29, 2012
Final Decision Transaction Processed By Ib
Aug 7, 2012
Final Disposition Notice Sent To Ib
Aug 7, 2012
Final Disposition Processed
Mar 13, 2012
Final Disposition Notice Created, To Be Sent To Ib
Dec 13, 2011
Registered-Principal Register
Sep 27, 2011
Published For Opposition
Sep 7, 2011
Notice Of Publication
Aug 22, 2011
Law Office Publication Review Completed
Aug 18, 2011
Examiners Amendment Mailed
Aug 18, 2011
Approved For Pub - Principal Register
Aug 18, 2011
Examiner's Amendment Entered
Aug 18, 2011
Examiners Amendment -Written
Aug 10, 2011
Teas/Email Correspondence Entered
Aug 10, 2011
Correspondence Received In Law Office
Aug 10, 2011
Teas Request For Reconsideration Received
May 25, 2011
Notification Of Possible Opposition - Processed By Ib
May 4, 2011
Notification Of Possible Opposition Sent To Ib
May 4, 2011
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 2, 2011
Assigned To Examiner
Feb 11, 2011
Final Refusal Mailed
Feb 10, 2011
Final Refusal Written
Jan 20, 2011
Lie Checked Susp - To Atty For Action
Jul 20, 2010
Letter Of Suspension Mailed
Jul 20, 2010
Suspension Letter Written
Jul 15, 2010
Teas/Email Correspondence Entered
Jul 15, 2010
Correspondence Received In Law Office
Jul 14, 2010
Assigned To Lie
Jun 29, 2010
Teas Response To Office Action Received
Jan 22, 2010
Refusal Processed By Ib
Dec 29, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Dec 29, 2009
Refusal Processed By Mpu
Dec 24, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Dec 23, 2009
Non-Final Action Written
Dec 16, 2009
Assigned To Examiner
Dec 11, 2009
Application Filing Receipt Mailed
Dec 7, 2009
New Application Office Supplied Data Entered In Tram
Dec 4, 2009
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
